Galapagos NV
GLPG
#4956
Rank
โ‚น178.18 B
Marketcap
โ‚น2,653
Share price
0.00%
Change (1 day)
8.20%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): โ‚น50.45 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น1.22 Billion. In 2025 the company made an earning of โ‚น35.19 Billion, an increase over its 2024 earnings that were of -โ‚น0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น50.45 B43.37%
2025 โ‚น35.19 B-6464.81%
2024 -โ‚น0.56 Billion-82.77%
2023 -โ‚น3.21 Billion-85.59%
2022 -โ‚น22.28 Billion60.71%
2021 -โ‚น13.87 Billion-60.08%
2020 -โ‚น34.73 Billion-331.44%
2019 โ‚น15.00 B-523.76%
2018 -โ‚น3.55 Billion-72.34%
2017 -โ‚น12.81 Billion-329.59%
2016 โ‚น5.57 B-144.3%
2015 -โ‚น12.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.485 T 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น778.54 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น631.20 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น732.76 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น1.258 T 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.403 T 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น957.89 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น5.12 Billion-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น217.28 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel